S4 Ep18: Behind the FDA Approval of Fruquintinib for Previously Treated mCRC

from Treating Together · host Targeted Oncology

In season 4, episode 18 of Targeted Talks, Arvind Dasari, MD, MS, dives into the recent approval of fruquintinib for patients with with metastatic colorectal cancer.

Episode metadata supplied by the publisher feed · Published Nov 15, 2023

Embed this episode

Attribution link and audio player

Ready to play

S4 Ep18: Behind the FDA Approval of Fruquintinib for Previously Treated mCRC

0:00 9:24

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Treating Together?

This episode is 9 minutes long.

When was this Treating Together episode published?

This episode was published on November 15, 2023.

Can I download this Treating Together episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!